AstraZeneca Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma
Conditions:   Borderline Resectable Carcinoma;   Biliary Tract Cancer Interventions:   Drug: Durvalumab;   Drug: Tremelimumab;   Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgical Resection Sponsors:   Georgetown University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials